tiprankstipranks
Benitec Biopharma Ltd (DE:BJ9)
FRANKFURT:BJ9
Germany Market
BJ9
Benitec Biopharma
RESEARCH TOOLSreports

Benitec Biopharma (BJ9) Ratios

1 Followers

Benitec Biopharma Ratios

DE:BJ9's free cash flow for Q3 2026 was AU$0.00. For the 2026 fiscal year, DE:BJ9's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 56.82 54.67 10.49 0.94 1.90
Quick Ratio
 56.82 54.67 10.49 0.94 1.90
Cash Ratio
 56.43 54.24 10.33 0.62 1.60
Solvency Ratio
 -13.20 -16.33 -4.31 -4.50 -5.76
Operating Cash Flow Ratio
 -6.28 -13.09 -3.94 -4.53 -6.28
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 182.35M$ 96.22M$ 46.71M$ -533.00K$ 1.73M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.13 0.14
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 2.77 0.28
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.73 0.22
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.02 1.02 1.11 22.10 2.07
Debt Service Coverage Ratio
 15.56 12.59 0.00 -580.24 -557.94
Interest Coverage Ratio
 15.69 12.71 0.00 -578.21 -557.94
Debt to Market Cap
 <0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
 -0.05 -0.07 0.03 0.43 0.44
Net Debt to EBITDA
 3.44 2.34 2.36 0.10 0.18
Profitability Margins
Gross Profit Margin
-14.21%0.00%0.00%-408.00%87.67%
EBIT Margin
-9701.08%0.00%0.00%-26038.67%-24898.63%
EBITDA Margin
-9615.65%0.00%0.00%-25530.67%-24457.53%
Operating Profit Margin
-9701.08%0.00%0.00%-25441.33%-24457.53%
Pretax Profit Margin
-8792.09%0.00%0.00%-26082.67%-24942.47%
Net Profit Margin
-8792.09%0.00%0.00%-26082.67%-24942.47%
Continuous Operations Profit Margin
-8792.09%0.00%0.00%-26082.67%-24942.47%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
90.63%90.79%96.25%102.52%101.98%
Return on Assets (ROA)
-26.14%-38.07%-41.66%-438.22%-304.84%
Return on Equity (ROE)
-34.82%-38.97%-46.04%-9684.16%-631.78%
Return on Capital Employed (ROCE)
-29.36%-42.71%-47.79%-3926.13%-518.86%
Return on Invested Capital (ROIC)
-29.28%-42.55%-47.50%-2507.36%-483.46%
Return on Tangible Assets
-26.14%-38.07%-41.66%-438.22%-304.84%
Earnings Yield
-8.12%-8.95%-29.20%-347.68%-48.02%
Efficiency Ratios
Receivables Turnover
 185.33 0.00 0.00 1.36 24.33
Payables Turnover
 1.00 1.97 0.25 0.33 0.02
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.61 0.00 0.00 0.12 0.07
Asset Turnover
 <0.01 0.00 0.00 0.02 0.01
Working Capital Turnover Ratio
 <0.01 0.00 0.00 0.07 <0.01
Cash Conversion Cycle
 -363.03 -185.27 -1.44K -824.46 -17.10K
Days of Sales Outstanding
 1.97 0.00 0.00 267.67 15.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 365.00 185.27 1.44K 1.09K 17.11K
Operating Cycle
 1.97 0.00 0.00 267.67 15.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.42 -0.65 -1.89 -13.00 -8.27
Free Cash Flow Per Share
 -0.42 -0.65 -1.91 -13.00 -8.28
CapEx Per Share
 <0.01 <0.01 0.02 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -747.58 -1.31K -108.40 -18.01K -1.22K
Capital Expenditure Coverage Ratio
 -747.58 -1.31K -108.40 -18.01K -1.22K
Operating Cash Flow Coverage Ratio
 -23.48 -27.78 -68.32 -32.22 -19.60
Operating Cash Flow to Sales Ratio
 -36.99 0.00 0.00 -240.16 -217.79
Free Cash Flow Yield
-4.92%-5.57%-26.29%-320.15%-41.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.98 -11.14 -3.43 -0.29 -2.08
Price-to-Sales (P/S) Ratio
 753.20 0.00 0.00 75.02 519.41
Price-to-Book (P/B) Ratio
 3.28 4.35 1.58 27.85 13.16
Price-to-Free Cash Flow (P/FCF) Ratio
 -20.33 -17.95 -3.80 -0.31 -2.38
Price-to-Operating Cash Flow Ratio
 -29.27 -17.96 -3.84 -0.31 -2.38
Price-to-Earnings Growth (PEG) Ratio
 -0.23 0.18 0.04 0.01 0.07
Price-to-Fair Value
 3.28 4.35 1.58 27.85 13.16
Enterprise Value Multiple
 -4.39 -7.90 -1.12 -0.19 -1.94
Enterprise Value
 234.89M 326.75M 23.92M 3.71M 34.67M
EV to EBITDA
 -4.39 -7.90 -1.12 -0.19 -1.94
EV to Sales
 422.47 0.00 0.00 49.45 474.87
EV to Free Cash Flow
 -11.41 -13.84 -1.22 -0.21 -2.18
EV to Operating Cash Flow
 -11.42 -13.85 -1.23 -0.21 -2.18
Tangible Book Value Per Share
 3.71 2.69 4.60 0.15 1.50
Shareholders’ Equity Per Share
 3.71 2.69 4.60 0.15 1.50
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.01 0.00 0.00 0.05 0.04
Net Income Per Share
 -0.99 -1.05 -2.12 -14.12 -9.47
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.91 0.91 1.00 1.00 1.00
Research & Development to Revenue
 34.53 0.00 0.00 170.32 154.41
SG&A to Revenue
 62.48 0.00 0.00 0.00 91.04
Stock-Based Compensation to Revenue
 22.59 0.00 0.00 6.03 11.92
Income Quality
 0.50 0.62 0.89 0.92 0.87